The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Afdhal Nezam H. since year 2005.
The trader's CIK number is 1664569.
At the time of this reporting, Afdhal Nezam H. is the Chief Medical Officer of Spring Bank Pharmaceuticals, Inc. .
(stock ticker symbol SBPH).
See this page for all insider trading activities at Spring Bank Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-09-09||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||2,400||12.50||30,000|
|2016-08-24||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||2,000||11.96||23,926|
|2016-08-16||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||100||11.49||1,149|
|2016-08-15||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||1,800||11.43||20,574|
|2016-08-12||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||2,600||11.33||29,450|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Afdhal Nezam H. (Chief Medical Officer of Spring Bank Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.